Large gap with delayed quotes
|
Last quote
07/11/2025
-
22:15:00
|
Bid
07/11/2025 -
21:59:59
|
Bid Volume |
Ask
07/11/2025 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
376.07
-2.25
(
-0.59% )
|
375.88
|
900 |
375.99
|
3,000 |
Analysis date: 11.07.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 04.07.2025.
Interest
Strong
Strong
Three stars since 10.06.2025.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 06.05.2025 at a price of 356.70.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 29.04.2025.
4wk Rel Perf
-0.40%
-0.40%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.06.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -1.27%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.67%.
Mkt Cap in $bn
91.01
91.01
With a market capitalization >$8bn, HCA HEALTHCARE is considered a large-cap stock.
G/PE Ratio
1.09
1.09
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
11.83
11.83
The estimated PE is for the year 2027.
LT Growth
12.10%
12.10%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
20
20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
0.78%
0.78%
The twelve month estimated dividend yield represents 9.21% of earnings forecasts.
Beta
25
25
For 1% of index variation, the stock varies on average by 0.25%.
Correlation
0.18
0.18
Stock movements are totally independent of index variations.
Value at Risk
45.17
45.17
The value at risk is estimated at USD 45.17. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
27.07.2011
27.07.2011